Characterization of human influenza viruses in lebanon during 2010-2011 and 2011-2012 post-pandemic seasons

dc.contributor.authorZaraket, Hassan
dc.contributor.authorDapat, Clyde P.
dc.contributor.authorGhanem, Soha T.
dc.contributor.authorAli, Zainab
dc.contributor.authorLteif, Mireille
dc.contributor.authorKondo, Hiroshi
dc.contributor.authorDapat, Isolde Caperig
dc.contributor.authorSaito, Kousuke
dc.contributor.authorKayali, Ghazi
dc.contributor.authorSuzuki, Hiroshi
dc.contributor.authorDbaibo, Ghassan S.
dc.contributor.authorSaito, Reiko
dc.contributor.departmentExperimental Pathology, Microbiology, and Immunology
dc.contributor.departmentPediatrics and Adolescent Medicine
dc.contributor.departmentDivision of Pediatric Infectious Diseases
dc.contributor.facultyFaculty of Medicine (FM)
dc.contributor.institutionAmerican University of Beirut
dc.date.accessioned2025-01-24T11:38:53Z
dc.date.available2025-01-24T11:38:53Z
dc.date.issued2014
dc.description.abstractObjective: To genetically characterize human influenza viruses and their susceptibilities to antivirals during two post-pandemic seasons in Lebanon.; Methods: Influenza virus was isolated from nasopharyngeal swabs that were obtained from patients with influenza-like illness during 2010-2012 and further analyzed both phenotypically and genotypically.; Results: During the 2010-2011 season, both 2009 pandemic H1N1 (H1N1p) and B viruses co-circulated with equal prevalence, while the H3N2 virus predominated during the 2011-2012 season. All H3N2 and H1N1 viruses were resistant to amantadine. Importantly, all viruses of the influenza A and B types were susceptible to the neuraminidase (NA) inhibitors oseltamivir, zanamivir, peramivir, and laninamivir. Nonetheless, all 2011-2012 H1N1p isolates had three mutations (V241I, N369K, and N386S) in the NA gene that were suggested to be permissive of the H275Y mutation, which confers resistance to oseltamivir. We also detected one H1N1p virus during the 2010-2011 season with a 4-fold decrease in susceptibility to oseltamivir due to an NA-S247N mutation. This isolate was phylogenetically distinct from other H1N1p viruses that were isolated in other regions.; Conclusions: Influenza A viruses with reduced susceptibility to oseltamivir and mutations permissive for acquiring NA resistance-conferring mutation with minimal burden on their fitness were isolated in Lebanon. © 2014 S. Karger AG, Basel.
dc.identifier.doihttps://doi.org/10.1159/000365758
dc.identifier.eid2-s2.0-84918804659
dc.identifier.pmid25301400
dc.identifier.urihttp://hdl.handle.net/10938/29087
dc.language.isoen
dc.publisherS. Karger AG
dc.relation.ispartofIntervirology
dc.sourceScopus
dc.subjectAntiviral drug susceptibility
dc.subjectInfluenza virus
dc.subjectLebanon
dc.subjectMiddle east
dc.subjectNeuraminidase inhibitors
dc.subjectPandemic h1n1
dc.subjectAmantadine
dc.subjectAntiviral agents
dc.subjectCyclopentanes
dc.subjectDrug resistance, viral
dc.subjectGuanidines
dc.subjectHumans
dc.subjectInfluenza a virus, h1n1 subtype
dc.subjectInfluenza a virus, h3n2 subtype
dc.subjectInfluenza b virus
dc.subjectInfluenza, human
dc.subjectMicrobial sensitivity tests
dc.subjectMutation
dc.subjectNeuraminidase
dc.subjectOseltamivir
dc.subjectPandemics
dc.subjectPhylogeny
dc.subjectZanamivir
dc.subjectCercopithecine herpesvirus 1
dc.subjectHuman influenza virus
dc.subjectInfluenza a virus
dc.subjectOrthomyxoviridae
dc.subjectLaninamivir
dc.subjectPeramivir
dc.subjectAntivirus agent
dc.subjectCyclopentane derivative
dc.subjectGuanidine derivative
dc.subjectSialidase
dc.subjectAntiviral susceptibility
dc.subjectArticle
dc.subjectControlled study
dc.subjectFlu like syndrome
dc.subjectGene mutation
dc.subjectGenetic analysis
dc.subjectGenetic susceptibility
dc.subjectHuman
dc.subjectIc50
dc.subjectInfluenza a
dc.subjectInfluenza b
dc.subjectInfluenza virus a
dc.subjectInfluenza virus a h1n1
dc.subjectInfluenza virus a h3n2
dc.subjectMajor clinical study
dc.subjectMolecular phylogeny
dc.subjectNasopharynx
dc.subjectNose smear
dc.subjectNucleotide sequence
dc.subjectPandemic influenza
dc.subjectPhenotypic variation
dc.subjectPrevalence
dc.subjectSeasonal influenza
dc.subjectSeasonal variation
dc.subjectVirus isolation
dc.subjectVirus resistance
dc.subjectAnalogs and derivatives
dc.subjectAntiviral resistance
dc.subjectDrug effects
dc.subjectGenetics
dc.subjectInfluenza virus b
dc.subjectIsolation and purification
dc.subjectMicrobial sensitivity test
dc.subjectPandemic
dc.subjectVirology
dc.titleCharacterization of human influenza viruses in lebanon during 2010-2011 and 2011-2012 post-pandemic seasons
dc.typeArticle

Files